The prognostic impact of tumour NSD2 expression in advanced prostate cancer.
Stangl-Kremser J, Lemberger U, Hassler MR, Garstka N, Grubmüller B, Haitel A, Enikeev DV, Glybochko PV, Kramer G, Susani M, Shariat SF.
Stangl-Kremser J, et al.
Biomarkers. 2020 May;25(3):268-273. doi: 10.1080/1354750X.2020.1734861. Epub 2020 Mar 2.
Biomarkers. 2020.
PMID: 32091270